Scinovex
article Open AccessTop 1% cited

Exopolysaccharide Produced by Probiotic Strain Lactobacillus paraplantarum BGCG11 Reduces Inflammatory Hyperalgesia in Rats

Frontiers in Pharmacology · 2018 · Vol. 9 · pp. 1–1
Miroslav DinićUroš PecikozaJelena DjokićRadica Stepanović‐PetrovićMarina MilenkovićMagdalena StevanovićNenad FilipovićJelena BegovićNataša GolićJovanka Lukić

Abstract

The aim of this study was to test the potential of high molecular weight exopolysaccharide (EPS) produced by the putative probiotic strain <i>Lactobacillus paraplantarum</i> BGCG11 (EPS CG11) to alleviate inflammatory pain in Wistar rats. The EPS CG11 was isolated from bacterial surface and was subjected to Fourier-transform infrared spectroscopy (FTIR) and thermal analysis. FTIR spectra confirmed the polysaccharide structure of isolated sample, while the thermal methods revealed good thermal properties of the polymer. The antihyperalgesic and antiedematous effects of the EPS CG11 were examined in the rat model of inflammation induced by carrageenan injection in hind paw. The results showed that the intraperitoneal administration of EPS CG11 produced a significant decrease in pain sensations (mechanical hyperalgesia) and a paw swelling in a dose-dependent manner as it was measured using Von Frey anesthesiometer and plethysmometer, respectively. These effects were followed by a decreased expression of <i>IL-1</i>β and <i>iNOS</i> mRNAs in rat's paw tissue suggesting that the antihyperalgesic and antiedematous effects of the EPS CG11 are related to the suppression of inflammatory response. Additionally, we demonstrated that EPS CG11 exhibits immunosuppressive properties in the peritonitis model induced by carrageenan. Expression levels of pro-inflammatory mediators IL-1β, TNF-α and iNOS were decreased, together with the enhanced secretion of anti-inflammatory IL-10 and IL-6 cytokines, while neutrophil infiltration was not changed. To the best of our knowledge, this is the first study which reports an antihyperalgesic effect as the novel property of bacterial EPSs. Given the high demands of pharmaceutical industry for the replacement of commonly used analgesics due to numerous side effects, this study describes a promising natural compound for the future pharmacological testing in the area.

Probiotics and Fermented FoodsNeuropeptides and Animal PhysiologyPharmacological Effects of Natural CompoundsCarrageenanHyperalgesiaChemistryPharmacologyProbioticLactobacillusInflammationIntraperitoneal injectionPolysaccharideIn vivo

Funding

  • Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Citations
390
FWCI
69.07
field-weighted impact
References
57
Percentile
100%
vs. same field & year
Citations per year
Cited by
Exopolysaccharides from probiotic bacteria and their health potential
International Journal of Biological Macromolecules · 2020 · 554 citations
Engineering precision nanoparticles for drug delivery
Nature Reviews Drug Discovery · 2020 · 6,985 citations
Delivery technologies for cancer immunotherapy
Nature Reviews Drug Discovery · 2019 · 2,556 citations
References
Spectrometric identification of organic compounds
Journal of Chemical Education · 1962 · 14,215 citations
Mechanisms of inflammatory pain
British Journal of Anaesthesia · 2001 · 574 citations
BIPHASIC DEVELOPMENT OF CARRAGEENIN EDEMA IN RATS
Journal of Pharmacology and Experimental Therapeutics · 1969 · 782 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.